Patent · US Active

Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism

US7638526B2 · kind B2 · utility

4Cited by

10References

6Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Brian McKittrick · New Vernon, US
Elizabeth M. Smith · Verona, US
Chad E. Bennett · Metuchen, US
Joel M. Harris · Summit, US
Eugenia Y. Kiselgof · Flemington, US
Chad Knutson · Garwood, US
Peter Korakas · Bound Brook, US
Deen Tulshian · Lebanon, US
Hyunjin Kim · Seoul, KR

Key dates

Filing date	Sep 13, 2007
Grant date	Dec 29, 2009
Priority date	—
Expiry date	Sep 13, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds of the formula:and compounds of the formula:wherein R1, R2, R3, R4, R5, u and v are as defined herein. Also disclosed are methods of treating pain (e.g., inflammatory pain, chronic pain, and neuropathic pain), methods of treating diabetes, and methods of inhibiting the absorption of cholesterol using compounds of formula I or IIA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.